Drug Discovery Market Reports

Find the information you need on the drug discovery industry. The Kalorama Information collection of research reports provides insights into product and market trends, analyses, opportunities, projections, sales, and marketing strategies. Specifics on market share, size, and growth in US and global markets are also featured. You’ll find the latest information regarding protein biomarkers, emerging cancer vaccines, emerging drug therapies, outsourcing trends, and more.

<< back 1 2 next >>

Title	Published	Price
The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) The anti-infective market is at a critical juncture. For the past 60 years, antibiotic drugs have turned bacterial infections into treatable conditions rather than the life-threatening scourges they once were. But the effectiveness of many antibiotics is waning dramatically, as more and more types of bacteria become resistant  |  more... Search inside this report	Oct 1, 2009	$3,500.00
World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers) The multi-billion veterinary health products market, though smaller in opportunity as compared with the human health sector, offers significant return on investment, primarily driven by lower risk and faster product development cycles. The veterinary health products market has remained resilient over the economic downturns of the past 2 decades. This  |  more... Search inside this report	May 1, 2009	$3,500.00
Clinical Nutrition Products: World Markets, 3rd Edition This Kalorama Information report - Clinical Nutrition - focuses on three primary segments of essential medical nutrition: Infant Nutrition: (Milk-based, Soy-based, Special Needs such as Chronic Reflux or Gastrointestinal Discomfort) Enteral Nutrition (Standard and Fiber-containing Elemental and Semi-elemental, Specialized for Chronically Ill Patients) Parenteral Nutrition For each category,  |  more... Search inside this report	Feb 1, 2009	$3,795.00
Pharmaceutical Outsourcing Post-Launch : Contract Manufacturing, Biomanufacturing and Sales, 3rd Edition This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing of prescription drugs and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing sector. A major factor driving the upward trend in the number of  |  more... Search inside this report	Jan 1, 2009	$3,500.00
Outsourcing in Drug Development: The Contract CRO Market, 3rd Edition Driven by mounting market pressures, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are reshaping the drug development services industry. Kalorama Information's Outsourcing in Drug Development is  |  more... Search inside this report	Oct 1, 2008	$3,500.00
Lab Automation Markets Worldwide (Next-Generation Systems, Key Companies, Forecasts and Trends) The benefits of automation in the clinical laboratory are well documented. They involve replacing manual, potentially dangerous, error-prone steps with automated processes requiring minimal operator intervention. This approach can increase productivity, decrease turnaround time, improve staff safety, minimize errors, improve the handling of specimens, and allow labs to reallocate personnel  |  more... Search inside this report	Aug 1, 2008	$3,500.00
The World Alzheimer's Disease Market (Incidence, Treatments, Key Companies, Pipeline and Trends) Alzheimer’s Disease is the most common cause of dementia, constituting 60% to 70% of all cases, and the risk with the disease doubles every 5 years after age 65. Incidence of the disease is increasing, and the resulting attention given to Alzheimer's Disease has encouraged development of new treatments.  |  more... Buy by the section | Search inside this report	Aug 1, 2008	$2,995.00
Outsourcing in Drug Discovery: The Contract Research (CRO) Market, 3rd Edition 2008 has seen no decrease in the opportunities available for outsourcing drug discovery, for a number of reasons. New technologies increase the number of targets and accelerate the identification of active compounds. There is increasing pressure to develop new lead compounds due to the near-term loss of patent  |  more... Search inside this report	May 1, 2008	$3,500.00
Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells. For market-watchers in the pharmaceutical industry, the  |  more... Buy by the section | Search inside this report	Mar 1, 2008	$3,995.00
Gene Expression Profiling Markets Parts of the gene expression analysis market continue to develop in a somewhat predictable manner, whereas other segments are becoming increasingly complex and volatile. The main products—microarrays and RT-PCR—continue to gain widespread acceptance and to see revenues grow rapidly. However, different products and applications are increasingly being introduced,  |  more... Search inside this report	Jan 1, 2008	$2,995.00
Worldwide Market for Rheumatoid Arthritis and Lupus Treatments ( Autoimmune Disease Markets ) Rheumatoid arthritis and lupus belong to a number of autoimmune diseases affecting the musculoskeletal system, multisystemic tissue, and connective tissues. Although a range of autoimmune conditions carry a low prevalence, combined these diseases amount to a growing medical and economic burden. Additionally, autoimmune diseases are accounting for a growing  |  more... Buy by the section | Search inside this report	Jan 1, 2008	$2,200.00
The World Cardiovascular Drug Market, (Antihypertensives, Antihyperlipidemics, Vasodilators, Anticoagulants, Diuretics and other Agents) Kalorama's 2nd edition of The World Cardiovascular Drugs Market , in its 2nd edition, will steer marketers through the sheer size and diversity of the current market and the potential of new products that will make this therapeutic category among the most competitive of prescription drug segments. Analyst Mary  |  more... Buy by the section | Search inside this report	Dec 1, 2007	$1,500.00
Analytical Chip Technology: U.S. Markets for Lab on a Chip, DNA/Gene, Protein, and other Microarrays, 3rd. Edition Analytical microchips can be considered one of the fastest growing technology segments in life sciences. The range of applications to which these miniature laboratories may be directed is very broad — covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis.  |  more... Buy by the section | Search inside this report	Nov 1, 2007	$1,995.00
Early Toxicology: Markets and Approaches Toxicity is a crucial parameter that is measured throughout the drug development process. Toxic side-effects are one of the most common reasons drug candidates fail. Toxicity can be a factor of dose, the form in which the drug is administered, and the time of exposure before elimination. Patient  |  more... Search inside this report	Jun 1, 2007	$2,800.00
Global Tuberculosis Diagnostics and Treatment Markets The importance, danger and costs of tuberculosis in the 21st century cannot be understated or underestimated. Though nearly extinct in the 20th century, over 1.6 billion people worldwide suffer from tuberculosis, and it is now presenting a major crisis in public health circles. As illustrated by Kenneth G.  |  more... Search inside this report	Jun 1, 2007	$1,395.00
Biomarkers: A Market Briefing Personalized medicine, the use of therapies that are targeted to the individual patient, is a reality today, thanks to a growing emphasis on biomarker research. Biomarkers promise a smoother integration of diagnostics and therapeutics, and most importantly a reduction in time and cost for Phase I and II clinical trials.  |  more... Search inside this report	Jan 1, 2007	$1,200.00
Mass Spectrometry in Protein Biomarker Applications: Software, Services, and Instrument Markets Protein biomarkers have become the hot application area for mass spectrometry (MS) and other proteomics-related technologies in the last few years. In the short term, this move towards biomarkers and clinical proteomics research has happened mainly in the drug discovery and development process. However, they also have broad  |  more... Buy by the section | Search inside this report	Nov 1, 2006	$1,100.00
Pharmaceutical Outsourcing Opportunities Post-Launch: Contract Manufacturing and Contract Sales and Marketing, 2nd Edition This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing sector. The report contains vital market statistics on three main segments of pharmaceutical contract  |  more... Buy by the section | Search inside this report	Sep 1, 2006	$3,900.00
Outsourcing in Drug Development: The Contract Research (CRO) Market, 2nd Edition CRO is a need-to know practice in pharmaceutical marketing today; but information is not always easy to find. This second edition of Kalorama’s best-selling look at the clinical contract research industry provides the key information competitors need to navigate the complexities and costs of clinical research in the drug  |  more... Buy by the section | Search inside this report	May 1, 2006	$3,500.00
Men's Health: The Market for Current and Emerging Drug Therapies, 2nd Edition This complete re-evaluation of the Men’s Health market focuses on the following prescription drug treatment segments: Men’s Cancer Men’s Sexual Dysfunction Men’s Sexually Transmitted Diseases Men’s Urinary Conditions Andropause The report covers drugs used for the treatment of prostate cancer, testicular cancer, impotence, premature ejaculation, and benign prostatic  |  more... Buy by the section | Search inside this report	May 1, 2006	$3,550.00
The Impact of the Phase III Pipeline: Future Projections and Market Disruptions There are hundreds of drugs in Phase III clinical trials, of which almost 200 of them may gain market approval from the FDA in the coming 5 years. Which drugs will make it and how these drugs impact existing pharmaceutical markets in terms of overall size and competitive share is  |  more... Buy by the section | Search inside this report	Mar 1, 2006	$3,500.00
Outsourcing in Drug Discovery, 2nd Edition In the Spring of 2003, Kalorama published its first report on Outsourcing in Drug Discovery. Since then, so much has changed, the use of the term "2nd Edition" hardly seems appropriate. This new study involved completely re-examining the market from the ground up. This new report is designed  |  more... Buy by the section | Search inside this report	Jan 1, 2006	$2,995.00
Informatics in Drug Discovery: The Evolving Information Technology Marketplace Within the world of life science research, informatics plays a key role. A few years ago, this market space was occupied primarily by a few niche players, but over the past five years, established companies have expanded their offerings and hundreds of new software companies have surfaced.  |  more... Buy by the section | Search inside this report	May 1, 2005	$3,000.00
Pharmaceutical Outsourcing Opportunities Post Launch: Contract Manufacturing, and Sales and Marketing After decades of sustained growth and profitability, the pharmaceutical industry has been positioned as one of the few recession proof industries based on its performance through multiple economical cycles. In recent years, there have been visible strains in the pharmaceutical business. With a downturn in fortunes, many pharmaceutical companies  |  more... Buy by the section | Search inside this report	Jul 1, 2004	$3,500.00
Early Stage Drug Discovery 2004: Combi-chem & High Throughput Screening Revisited Ten years ago, high throughput screening (HTS) was being touted as the answer to improving productivity in drug discovery. If screening thousands of compounds a week was good, screening hundreds of thousands would be even better. This led to the boom in Ultra HTS (UHTS), manufacturing-scale systems, and  |  more... Buy by the section | Search inside this report	Jun 1, 2004	$2,995.00
Title	Published	Price

<< back 1 2 next >>